Clinical trial
Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Lassa Fever Patients in Nigeria: a Prospective Observational Cohort Study
NCT04285034 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Lassa Fever Patients in Nigeria: a Prospective Observational Cohort Study
- Lead sponsor
- University of Oxford
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 26, 2019
- Completion date
- July 15, 2021
- Enrollment
- 158 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.